Español 
English 
Wegovy: Introduction to Revolutionizing Weight Loss
Have you heard of Wegovy? It’s a new and popular medication recently approved by the FDA for chronic weight management in adults who are overweight or obese and have at least one weight-related condition. Wegovy works by activating the GLP-1 receptor in the brain, which helps to reduce appetite and increase feelings of fullness, thereby promoting weight loss.
Wegovy comes in the form of a subcutaneous injection that is given once a week. It’s a long-acting version of semaglutide, which is also used to treat type 2 diabetes. Your healthcare provider will administer the medication, but with proper training, you can self-administer it.
Clinical trials for Wegovy have shown that it’s highly effective for weight loss. Patients who received Wegovy lost an average of 15-16% of their body weight after 68 weeks of treatment, compared to only 2.4-5.7% for those who received a placebo.
While Wegovy has been shown to be safe and effective for weight loss in individuals who are overweight or obese and have at least one weight-related condition, like any medication, it may cause side effects in some people. The most common side effects of Wegovy include gastrointestinal symptoms, such as nausea, diarrhea, vomiting, constipation, and stomach pain. Other potential side effects include pancreatitis, gallbladder problems, hypoglycemia, kidney problems, and allergic reactions.
It’s essential to keep in mind that Wegovy is not a magical solution for weight loss. It should only be used in combination with a healthy diet and regular exercise. Additionally, it may not be suitable for everyone, particularly individuals with a history of pancreatitis or certain other medical conditions. So, it’s important to consult with your healthcare provider before starting treatment with Wegovy to determine if it’s an appropriate and safe option for weight loss.
Summary:
- Wegovy is a medication approved by the FDA for chronic weight management in adults who are overweight or obese and have at least one weight-related condition.
- It works by reducing appetite and increasing feelings of fullness, promoting weight loss.
- Wegovy is a long-acting version of semaglutide, which is also used to treat type 2 diabetes.
- Clinical trials have shown that Wegovy is highly effective for weight loss, with patients losing an average of 15-16% of their body weight after 68 weeks of treatment.
- The medication is administered by a healthcare provider and can be self-administered by patients after proper training.
- Common side effects include gastrointestinal symptoms, such as nausea, diarrhea, vomiting, constipation, and stomach pain, as well as more serious potential side effects like pancreatitis, gallbladder problems, hypoglycemia, kidney problems, and allergic reactions.
- It’s important to use Wegovy in combination with a healthy diet and regular exercise and consult with a healthcare provider to determine if it is an appropriate and safe option for weight loss.
- Read more about WeGovy and dieting do’s and don’ts
Take the first step towards achieving your weight loss goals by scheduling an appointment with our medical provider through Umedoc today.
This article reviewed by Dr. Jim Liu, MD and Ms. Deb Dooley, APRN.
There’s nothing more important than our good health – that’s our principal capital asset.
#medical #telehealth #umedoc
